chloroquine and ro13-9904

chloroquine has been researched along with ro13-9904 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altinay, G; Ermantaş, N; Okten, O; Oktun, MT; Soy, M; Tunçbilek, N; Turgut, B1
Chitnis, DS; Khan, YZ; Rao, G1
Fenollar, F; Feurle, GE; Moos, V; Raoult, D; Schneider, T1

Other Studies

3 other study(ies) available for chloroquine and ro13-9904

ArticleYear
Nocardiosis in a patient with primary anti-phospholipid syndrome.
    Rheumatology international, 2006, Volume: 26, Issue:5

    Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Antiphospholipid Syndrome; Antirheumatic Agents; Ceftriaxone; Chloroquine; Female; Humans; Immunocompromised Host; Methylprednisolone; Nocardia Infections; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination

2006
Chikungunya infection in neonates.
    Indian pediatrics, 2008, Volume: 45, Issue:3

    Topics: Alphavirus Infections; Anti-Bacterial Agents; Ceftriaxone; Chikungunya virus; Chloroquine; Humans; Infant, Newborn; Male; Risk Factors

2008
The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to treatment with ceftriaxone, meropenem and co-trimoxazole.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:5

    Topics: Anti-Bacterial Agents; Ceftriaxone; Central Nervous System Diseases; Chloroquine; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Male; Meropenem; Microbial Sensitivity Tests; Minocycline; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Whipple Disease

2012